Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target KG Arun, CS Sharanya, J Abhithaj, D Francis, C Sadasivan Journal of Biomolecular Structure and Dynamics 39 (13), 4647-4658, 2021 | 86 | 2021 |
Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro J Abhithaj, F Dileep, CS Sharanya, KG Arun, C Sadasivan, V Jayadevi J. Biomol. Struct. Dyn 40 (1), 325-336, 2022 | 30 | 2022 |
Derivatives Form Better Lipoxygenase Inhibitors than Piperine: In Vitro and In Silico Study MJ Tomy, CS Sharanya, KV Dileep, S Prasanth, A Sabu, C Sadasivan, ... Chemical Biology & Drug Design 85 (6), 715-721, 2015 | 28 | 2015 |
Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review CS Sharanya, A Sabu, M Haridas Future Journal of Pharmaceutical Sciences 7 (1), 113, 2021 | 26 | 2021 |
Health functions and related molecular mechanisms of ellagitannin-derived urolithins GR Gandhi, PJ Antony, SA Ceasar, ABS Vasconcelos, MM Montalvão, ... Critical Reviews in Food Science and Nutrition 64 (2), 280-310, 2024 | 22 | 2024 |
Streptococcus pneumoniae surface protein PfbA is a versatile multidomain and multiligand‐binding adhesin employing different binding mechanisms DSJ Beulin, D Radhakrishnan, SC Suresh, C Sadasivan, M Yamaguchi, ... The FEBS Journal 284 (20), 3404-3421, 2017 | 20 | 2017 |
Aloe emodin shows high affinity to active site and low affinity to two other sites to result consummately reduced inhibition of lipoxygenase CS Sharanya, KG Arun, A Sabu, M Haridas Prostaglandins & Other Lipid Mediators 150, 106453, 2020 | 15 | 2020 |
Inhibitory activity of hibifolin on adenosine deaminase- experimental and molecular modeling study AKCSSSPMC Sadasivan Computational biology and chemistry, 2016 | 14 | 2016 |
Designing of enzyme inhibitors based on active site specificity: lessons from methyl gallate and its lipoxygenase inhibitory profile. HM CS Sharanya, KG Arun, V Vijaytha, Sabu A J Recept Signal Transduct Res, 1-10, 2018 | 12* | 2018 |
In vitro Assessment of Selected Benzoic Acid Derivatives as Anti-Inflammatory Compounds MJ Tomy, CS Sharanya, DK Mahapatra, KI Suresh, A Sabu, M Haridas NISCAIR-CSIR, India, 2018 | 12 | 2018 |
Plant metabolites: methods, applications and prospects CS Sharanya, A Sabu, M Haridas, ST Skumaran, S Sugathan, ... Singapore: Springer, 2020 | 11 | 2020 |
Drug repurposing to identify therapeutics against COVID 19 with SARS-Cov-2 spike glycoprotein and main protease as targets: an in silico study CS Sharanya, J Abhithaj, C Sadasivan | 10 | 2020 |
Plant metabolomics: current status and prospects CS Sharanya, A Sabu, M Haridas Plant metabolites: methods, applications and prospects, 1-22, 2020 | 10 | 2020 |
Biochemical and computational insights of adenosine deaminase inhibition by Epigallocatechin gallate KG Arun, CS Sharanya, J Abhithaj, C Sadasivan Computational Biology and Chemistry 83, 107111, 2019 | 10 | 2019 |
Computational and experimental validation of morin as adenosine deaminase inhibitor KG Arun, CS Sharanya, C Sadasivan Journal of Receptors and Signal Transduction 38 (3), 240-245, 2018 | 9 | 2018 |
Multitargeted molecular docking and dynamics simulation studies of flavonoids and volatile components from the peel of Citrus sinensis L. (Osbeck) against specific … G Rajiv Gandhi, CS Sharanya, A Jayanandan, M Haridas, V Edwin Hillary, ... Journal of Biomolecular Structure and Dynamics 42 (6), 3051-3080, 2024 | 8 | 2024 |
Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors CS Sharanya, DS Wilbee, SN Sathi, K Natarajan Scientific Reports 14 (1), 16197, 2024 | 7 | 2024 |
Design, synthesis and SAR studies of novel tacrine derivatives as potent cholinesterase inhibitors B Dogga, EK Reddy, CS Sharanya, J Abhithaj, KG Arun, CSA Kumar, ... European Journal of Medicinal Chemistry Reports 6, 100094, 2022 | 7 | 2022 |
Drug repurposing for COVID-19 from FDA approved and experiment stage drugs by in silico methods with SARS CoV-2 spike protein CS Sharanya, J Abhithaj, A Sabu, H Madathilkovilakathu | 7 | 2020 |
Lipoxygenase inhibitory synthetic derivatives of methyl gallate regulate gene expressions of COX-2 and cytokines to reduce animal model arthritis CS Sharanya, J Abhithaj, KG Arun, KR Eeda, V Bhat, EJ Variyar, A Sabu, ... Scientific Reports 13 (1), 10644, 2023 | 3 | 2023 |